Hanger Announces Findings of Newly Published Study That Reveals Significant Cost Benefits Associated With Earlier Prosthetic ...
June 02 2020 - 9:00AM
Business Wire
Published in the American Journal of Physical Medicine and
Rehabilitation, the IMPACT study found a 25 percent reduction in
total healthcare costs associated with earlier prosthetic care
Hanger, Inc. (NYSE: HNGR) today announced results of its IMPACT
study, which evaluates the impact of overall healthcare costs
associated with the timing of definitive fitting and delivery of a
lower limb prosthesis following amputation. The IMPACT study
utilized the IBM Watson Truven Health Marketscan, a national
commercial claims database, and analyzed data on 510 patients with
lower limb amputations. Results suggest that delaying or not
providing a prosthesis increases direct healthcare costs by
approximately 25 percent over the initial 12 months
post-amputation. Further, earlier receipt of a prosthesis was
associated with reduced direct healthcare spending in the same time
period of approximately $25,000. The clinical research was peer
reviewed and published in a Medline indexed journal, the respected
American Journal of Physical Medicine and Rehabilitation.
“In light of previous studies that have demonstrated a link
between prosthetic mobility and quality of life, the fact that a
patient can receive a prosthesis as far as nine months
post-amputation, with no increased costs compared to someone who
does not receive a prosthesis, further demonstrates the holistic
value of prosthetic rehabilitation,” stated James Campbell, PhD,
Hanger Chief Clinical Officer.
Researchers in the clinical and scientific affairs department of
Hanger Clinic, including Shane R. Wurdeman, PhD, CP, FAAOP and
Taavy Miller, MSPO, CPO, accompanied by researchers from the
University of North Carolina at Charlotte’s Department of Public
Health, used generalized linear multivariate modeling to determine
differences in direct healthcare costs in the 12 months
post-amputation between groups based on timing of prosthesis
receipt as well as a control group with no prosthesis. Results
showed receipt of a prosthesis within three months post-lower limb
amputation yielded a reduced total cost by approximately 25 percent
within 12 months following amputation when compared to the
no-prosthesis group. Additionally, individuals who still received a
prosthesis within nine months post-amputation incurred costs
similar to the no-prosthesis group despite the included costs of a
prosthesis.
“As the leader in our profession, it is our responsibility to
provide objective clinical insight to support professionals in
making informed, unbiased decisions about appropriate patient
care,” stated Hanger President and Chief Executive Officer Vinit
Asar. “Not only does prosthetic care help individuals reintegrate
as productive members of society with an improved quality of life,
but these findings are significant as they demonstrate the added
value of a prosthesis in cost savings to the healthcare
system.”
The IMPACT study is an initial manuscript based on review of the
Watson data, with additional work to follow. The results of the
study are set to be published in an upcoming hardcopy print edition
American Journal of Physical Medicine and Rehabilitation, and are
available via early release online here:
https://journals.lww.com/ajpmr/Abstract/9000/Impact_of_Time_to_Receipt_of_Prosthesis_on_Total.97983.aspx.
The IMPACT series is part of a vast collection of landmark research
studies already published, or in various stages of publication by
Hanger Clinic’s Clinical and Scientific Affairs Department, in
collaboration with leading researchers, clinical, and academic
institutions. Additional information on previously published
research can be found here:
https://hangerclinic.com/for-professionals/research-innovation/.
About Hanger, Inc – Built on the legacy of James Edward
Hanger, the first amputee of the American Civil War, Hanger, Inc.
(NYSE: HNGR) delivers orthotic and prosthetic (O&P) patient
care, and distributes O&P products and rehabilitative solutions
to the broader market. Hanger's Patient Care segment is the largest
owner and operator of O&P patient care clinics with
approximately 800 patient care locations nationwide. Through its
Products & Services segment, Hanger distributes branded and
private label O&P devices, products and components, and
provides rehabilitative solutions. With over 150 years of clinical
excellence and innovation, Hanger's vision is to lead the orthotic
& prosthetic markets by providing superior patient care,
outcomes, services and value. For more information on Hanger, visit
www.hanger.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200602005122/en/
Public Relations & Communications Contact: Krisita
Burket, Vice President, Public Relations & Communications,
Hanger, Inc. 904-239-4627, kburket@hanger.com
Hanger (NYSE:HNGR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Hanger (NYSE:HNGR)
Historical Stock Chart
From Apr 2023 to Apr 2024